| Antifungal agent | No. (%) of courses of chemotherapy n = 136 |
|---|---|
| Monotherapy | |
| Fluconazole | 37 (27.2) |
| Echinocandin* | 9 (6.6) |
| Antifungal azole | 5 (3.7)† |
| Amphotericin B | 0 (0) |
| Combination therapy | |
| Fluconazole + echinocandin | 46 (33.8) |
| Fluconazole + echinocandin + antifungal azole | 17 (12.5)‡ |
| Echinocandin + antifungal azole | 10 (7.4) |
| Other combinations§ | 12 (8.8) |
*Echinocandin consisted of caspofungin and/or micafungin. †Posaconazole for 4 courses of chemotherapy and voriconazole for 1 course. ‡The antifungal azole was posaconazole for 8 courses of chemotherapy, voriconazole for 8 courses, and both posaconazole and voriconazole for 1 course (total 17 courses). §Fluconazole + antifungal azoles (n = 3 courses), fluconazole + caspofungin + amphotericin B (n = 1 course), fluconazole + antifungal azole + amphotericin B (n = 2 courses), fluconazole + caspofungin + antifungal azole + amphotericin B (n = 3 courses), caspofungin + antifungal azole + amphotericin B (n = 2 courses), antifungal azole + amphotericin B (n = 1 course).